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Background: Needle-syringe exchange programs (NSPs) have been substantially rolled-out in China since 2002. Limited
studies reported effectiveness of NSPs in a Chinese setting. This study aimed to assess the association between
accessibility to NSPs and drug-use risk behaviors of IDUs by investigating primary (self-reported) data of IDUs recruited
from NSP sites, community settings and mandatory detoxification centers (MDCs) in Hunan province, China.
Methods: A cross-sectional survey was conducted in Hunan province in 2010. IDU recruits participated in a face-to-face
interview to provide information related to their ability to access NSPs, demographic characteristics, and injecting
behaviors in the past 30 days.
Results: Of the total 402 participants, 35%, 14% and 51% participants indicated low, medium and high ability
to access NSPs in the past 30 days, respectively. A significantly higher proportion of IDUs (77.3%) from the
high-access group reported ≤2 injecting episodes per day compared with medium- (46.3%) and low-access
(58.8%) groups. Only 29.0% of high-access IDUs re-used syringes before disposal in the past 30 days,
significantly lower than those in the medium- (43.1%) and low-access (41.3%) groups. Reported levels of
needle/syringe sharing decreased significantly as the ability to access NSPs increased (16.3%, 12.7% and 2.5% in
the low, medium and high access groups, respectively). Ninety percent of IDUs recruited from MDCs had low
ability to access NSPs.
Conclusions: Increased NSP accessibility is associated with decreased levels of injecting frequency, repetitive use
and sharing of injecting equipment among Chinese IDUs. Mandatory detention of IDUs remains as a major
barrier for IDUs to access NSPs in China.Introduction
HIV epidemics usually first emerge in China among people
who inject drugs. HIV prevalence among injecting drug
users (IDUs) in southwest and northwest China has stabi-
lized at ~20% in the past decade [1-4], with infection
spreading across to in other at-risk populations and the
general population [5,6]. By 2009, 32.2% of the estimated
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reproduction in any medium, provided the orthrough sharing of injecting equipment [1]. Needle-syringe
exchange programs (NSPs) have been progressively rolled-
out in major Chinese cities since 2002 [8]. By 2010, a
total of 1023 NSPs sites have been established across
453 Chinese counties [9]. Access by IDUs to NSPs is
largely associated with awareness of the programs, extent
of police presence and risk of incarceration [10]. Illicit
drug use is punishable by law in China. Upon arrest,
IDUs are often directed to methadone maintenance ther-
apy (MMT) clinics under supervision of the police. If re-
lapse occurs during treatment, they are transferred to
mandatory detoxification centers (MDCs) or labor camps
for a period of between one and three years for com-
pulsory drug rehabilitation [11-13]. In these institutions,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Demographic Characteristics, NSP accessibility
and diseases prevalence levels among recruited IDUs
Characteristics N Percent (%)
Venue of recruitment (n = 402)
Needle and syringe program 153 38.1
Mandatory Detoxification Centers 78 19.4
Community 171 42.5
Gender (n = 402)
Male 333 82.8
Female 69 17.2






Average (±SD) 34.57 ± 7.05
Ethnic (n = 400)
Han 394 98.5
Non-Han 6 1.5
Education (n = 402)
Primary or below 86 21.4
Junior high school 252 62.7
Secondary high school 54 13.4
College or above 10 2.5
Marital Status (n = 402)
Single 166 41.3
Married and cohabited 139 34.6
Divorced and widowed 97 24.1
Currently employed (n = 395)
Yes 30 7.5
No 365 92.5
Respondents' accessibility to NSP (n = 402)
High (>70%) 142 35.3
Medium (40-70%) 55 13.7
Low (<40%) 205 51.0
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existent. Currently, institution-based interventions, includ-
ing mandatory detoxification, voluntary rehabilitation and
MMT, cover only 15% of the total drug users population
[14], indicating a large gap for the scale-up of community-
based interventions, such as NSPs.
NSPs have been shown to be a safe and effective
means to reduce syringe sharing and subsequent HIV
transmission among IDUs in various settings [15-20].
Although NSPs have been implemented for almost a
decade in China, only limited studies evaluate the ef-
fectiveness of NSPs in alleviating risk behaviors among
Chinese IDUs and all have been conducted in high-HIV
transmission provinces (Sichuan [21], Guangxi [21,22]
and Guangdong [22,23]). Based on a cross-sectional
study design, this study further investigates (1) the
association between the ability to access NSPs and
injecting behaviors in a low-HIV transmission setting;
and (2) the impact of mandatory detention on IDUs’
ability to access NSPs.
Methods
Study site, design and population
Hunan province is located in South China, bordered by
Guangdong and Guangxi provinces to the south and
Guizhou province to the west. All three adjacent prov-
inces are traditional drug-trafficking provinces with ex-
ceptionally high HIV prevalence levels among IDUs [1].
Hunan’s location has led to its role of channeling illicit
drugs to other Chinese provinces [24]. A cross-sectional
survey was conducted in three cities (Hengyang, Yiyang
and Huaihua) of Hunan province from September to
October 2010. Study participants were recruited from
the community, NSP sites and MDCs. Community IDUs
were recruited by outreach and peer-referral, whereas
IDUs from NSP sites and MDC were recruited at venues.
In MDCs, only IDUs admitted recently (<3 months) were
recruited to recall their injecting behaviors 30 days be-
fore their incarceration. Recent MDC entrants were par-
ticularly chosen to reduce recall bias.
Upon informed consent, participants completed a
30-minute questionnaire through face-to-face interviews;
no identifying personal information was collected. The
standardized questionnaire included questions related to
demographic characteristics and injecting behaviors in the
last 30 days (Table 1). In particular, the participants’ ability
to access NSPs was measured as the proportion of needle/
syringes obtained from NSPs in the past three months. For
incarcerated drug users, this refers to their ability to access
before incarceration.
Statistical analysis
Questionnaire data were double-entered and checked
in EpiData (v3.0). For analyses, study participants werestratified into groups according to (1) their ability to
access NSPs (i.e. low-access [<40%], medium-access
[40-70%] and high-access groups [>70%]) and (2) their
venue of recruitment (Table 2). Descriptive statistics were
calculated in the Statistical Package for the Social Sci-
ences (v19) for Windows. Chi-square tests were used to
assess differences between groups.
Ethical considerations
Ethics approval was obtained from the Institutional Re-
view Board of the Tsinghua University (Project Code:
Table 2 Injecting and sharing behaviors among 402 recruited IDUs
Overall Ability to access to NSP syringes‡ χ2-test Venue stratification χ2-test
<40% 40-70% >70% (χ2, p-value) MDC Community NSP (χ2, p value)
N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Used drugs in the last 30 days (n = 402)*
Yes 398 (99.0) 139 (97.9) 55 (100) 204 (99.5) 74 (94.9) 171 (100) 153 (100)
No 4 (1.0) 3 (2.1) 0 (0) 1 (0.5) 2.89, p = 0.236 4 (5.1) 0 (0) 0 (0) 16.782, p < 0.001†
Frequency of injecting drugs in the last 30 days (n = 392)
<1 times / day 41 (10.5) 12 (8.8) 4 (7.4) 25 (12.4) 7 (9.6) 19 (11.1) 15 (10.1)
1-2 times / day 220 (56.1) 68 (50.0) 21 (38.9) 131 (64.9) 37 (50.7) 109 (63.7) 74 (50.0)
3-5 times / day 115 (29.3) 46 (33.8) 28 (51.9) 41 (20.3) 22 (30.1) 39 (22.8) 54 (36.5)
>6 times / day 16 (4.1) 10 (7.4) 1 (1.9) 5 (2.5) 29.439, p < 0.001† 7 (9.6) 4 (2.3) 5 (3.4) 15.236, p = 0.019†
Times of repeated use per needle/syringe before disposal in the last 30 days (n = 389)
0 4 (1.0) 0 (0) 3 (5.9) 1 (0.5) 0 (0) 0 (0) 4 (2.7)
1 248 (63.8) 81 (58.7) 26 (51.0) 141 (70.5) 49 (66.2) 111 (65.7) 88 (60.3)
2-5 131 (33.7) 54 (39.1) 22 (43.1) 55 (27.5) 21 (28.4) 57 (33.7) 53 (36.3)
6-9 1 (0.3) 1 (0.7) 0 (0) 0 (0) 1 (1.4) 0 (0) 0 (0)
≥10 5 (1.3) 2 (1.4) 0 (0) 3 (1.5) 6.84, p = 0.033† 3 (4.1) 1 (0.6) 1 (0.7) 0.151, p = 0.927
Average ± SD 1.62 ± 1.32 1.80 ± 1.45 1.55 ± 0.86 1.52 ± 1.31 1.93 ± 2.00 1.54 ± 1.05 1.56 ± 1.13
Shared syringes in the last 30 days (n = 400)
Yes 35 (8.8) 23 (16.3) 7 (12.7) 5 (2.5) 15 (19.5) 4 (2.3) 16 (10.5)
No 365 (91.2) 118 (83.7) 48 (87.3) 199 (97.5) 21.326, p < 0.001† 62 (80.5) 167 (97.7) 136 (89.5) 20.507, p < 0.001†
Number of times shared syringes in the last 30 days (n = 29)
1 10 (34.5) 9 (45.0) 1 (16.7) 0 (0) 8 (66.7) 0 (0) 2 (15.4)
2-5 16 (55.2) 9 (45.0) 5 (83.3) 2 (66.7) 4 (33.3) 3 (75.0) 9 (69.2)
≥6 3 (10.3) 2 (10.0) 0 (0) 1 (33.3) 4.83, p = 0.090 0 (0) 1 (25.0) 2 (15.4) 5.780, p = 0.056
Average ± SD 4.28 ± 6.85 4.15 ± 7.37 2.17 ± 0.98 9.33 ± 9.29 1.55 ± 0.93 6.75 ± 8.85 5.92 ± 8.78
Number of sharing partners in the last 30 days (n = 31)
1 10 (31.3) 5 (22.7) 5 (71.4) 0 (0) 4 (28.6) 1 (25.0) 5 (35.7)
2-5 20 (62.5) 15 (68.3) 2 (28.6) 3 (100) 9 (64.3) 3 (75.0) 8 (57.1)
6-9 1 (3.1) 1 (4.5) 0 (0) 0 (0) 0 (0) 0 (0) 1 (7.1)
≥10 1 (3.1) 1 (4.5) 0 (0) 0 (0) 6.73, p = 0.035† 1 (7.1%) 0 (0) 0 (0) 0.594, p = 0.743
Average ± SD 2.53 ± 1.98 2.82 ± 2.26 1.43 ± 0.79 3.00 ± 0.0 2.64 ± 2.50 2.25 ± 0.96 2.85 ± 1.99
Maximum number of group sharing partners in the last 30 days (n = 32)
1 2 (6.3) 1 (4.5) 1 (14.3) 0 (0) 1 (7.1) 0 (0) 1 (7.1)
2-5 28 (87.5) 20 (90.9) 5 (71.4) 3 (100) 13 (92.9) 4 (100) 11 (78.6)
6-9 2 (6.3) 1 (4.5) 1 (14.3) 0 (0) 3.19, p = 0.203 0 (0) 0 (0) 2 (14.3) 0.867, p = 0.648
Average ± SD 2.94 ± 1.68 2.86 ± 1.42 3.00 ± 2.71 3.33 ± 0.58 2.50 ± 0.76 2.50 ± 0.58 3.50 ± 2.35
‡ Ability to access to NSP syringes is defined as the proportion of syringes obtained from NSPs during the past 3 months at the time of survey.
† p-value is significantly (<0.05) by Chi-2 test.
* Number in bracket refers to the number of participants who answered the particular question.
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and anonymous with no names and personal informa-
tion obtained. Verbal and written consent procedures
were provided to all participants before the survey, and
they had the right to withdraw from the study at any
time without penalty.Results
Characteristics of study participants
A total of 402 IDUs (community 42.5%; NSP sites 38.1%;
MDC 19.4%) participated in this study. Of all participants,
333 were male and 69 were female. Ages ranged between
17 to 56 years (mean 34.6 ± 7.1 years). The majority of
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ior high school (84.1%), was currently unemployed (92.5%)
and was single/divorced (65.4%) (Table 1). About 35%, 14%
and 51% of participants reported low, medium and high
ability to access NSPs in the past three months. Ninety per-
cent (90%) of IDUs recruited from MDCs had low ability
to access NSPs, much higher than recruits from commu-
nity (24.6%) and NSP sites (19.0%). In contrast, 62.0% and
61.4% of community and NSP recruits obtained >70%
of their syringes from NSPs, whereas only 6.3% of re-
cent MDC entrants obtained this level of their syrin-
ges from NSPs.
Injection risk behaviors
Almost all (99%) IDUs injected and consumed heroin
exclusively (97.0%) in the past 30 days. A significantly
higher proportion of IDUs in the high-access group
(77.3%) reported no more than two injecting episodes
per day compared with low (58.8%) and medium-access
groups (46.3%) (χ2 = 29.44, p < 0.001). When stratified by
recruitment venues, the proportion (74.8%) of IDUs
reporting no more than two injecting episodes per day is
significantly higher among community IDUs than those
from NSP sites (60.1%) and MDCs (60.3%) (χ2 = 15.24,
p = 0.019). Only 29.0% of high-access IDUs reported
having re-used syringes before disposal in the past
30 days, significantly lower than the medium and low-
access groups (43.1% and 41.3% respectively) (χ2 = 6.84,
p = 0.033). Pattern of repeated use of syringes did not
vary substantially across recruitment venues (Table 2).
Rates of needle/syringe sharing decreased substantially
as ability to access NSPs increased (16.3%, 12.7% and
2.5% in the low-, medium- and high-access groups re-
spectively). Respondents from MDCs had the highest
syringe sharing rate (19.5%) 30 days prior to their incar-
ceration in comparison with recruits from community
(2.3%) and NSP sites (10.5%) (χ2 = 20.51, p < 0.001).
Among those who shared syringes, an IDU shared on an
average of 4.28 ± 6.85 occasions with 2.53 ± 1.98 sharing
partners. The average sharing group size is approxi-
mately three (Table 2).
Discussion
Consistent with previous findings in both international
[25-30] and Chinese settings [21-23], our findings indi-
cate that provision of clean needle/syringes does not
increase the injecting frequency among IDUs, and fur-
thermore that increased availability of clean needles/
syringes may substantially contribute to the reduction
in repeated use of dull syringes and sharing activities
among Chinese IDUs. Liu et.al., in 2007, demonstrate
that the rate of syringe sharing in the past 30 days
among IDUs who regularly attend NSPs (15%) is two
to three times lower than non-attendees (32-44%) inGuangxi and Sichuan provinces [21]. Wu et.al., through
a 12-month cohort study, show that the sharing rate
dropped from 68% to 35% in the NSP intervention
community in South China. Although, in comparison,
IDUs in Hunan have a much lower sharing rate in gen-
eral (low-access group: 16.3%), an increased ability to
access NSPs is associated with substantial reductions in
sharing behaviors (high-access group: 2.5%).
IDU recruits from MDCs exhibit significantly higher
sharing rates, indicating a higher level of risk behaviors.
Lower ability to access NSPs prior to their incarceration
also suggests that the participation in MMT and likely
police supervision may have prevented IDUs from
accessing NSPs. In contrast, approximately two-thirds of
the community and NSP recruits obtained more than
80% of their syringes from NSPs, suggesting NSPs are
generally available and accessible to the majority of IDUs
outside of the detention settings. In addition, confine-
ment in MDCs does not reduce drug use behaviors
[31-33] and as high as 95% of IDUs relapse for drug ad-
diction within one year of release [34]. Detainees also
have limited access to health information and education
that are often associated with NSPs. Together with our
findings, this indicates that mandatory detoxification
may be a major obstacle for harm reduction programs
and improving risk behaviors for Chinese IDUs.
The first major limitation of this study is its cross-
sectional design. This does not enable us to directly
investigate the causal relationship between NSP accessi-
bility and its direct impact on drug use behaviors,
although it provides an association analysis between the
two. Second, the ability to access NSPs is defined as the
self-reported percentage of acquired NSPs syringes in
the past three months, which may be subjected to self-
recall bias. Third, although the study has been carefully
designed to obtain information of injecting behaviors of
recent MDC entrants prior to their admittance, the in-
formation may underestimate their actual risk behaviors
due to prior harm reduction programs (e.g. MMT)
[35,36] and the temporary abstinence of injecting be-
haviors during the transferring process to MDCs by
the police.
Our study has clearly demonstrated behavioral im-
provements when the ability to access NSPs increases in
China. In addition, NSPs have been shown to be highly
cost-effective in both international [37-40] and Chinese
settings [41]. Full scale roll-out of NSPs should be
implemented as a major component of harm reduction
strategies nationwide. However, continued law enforce-
ment and mandatory detoxification remain as major bar-
riers to the necessary program scale-up and may even
counteract the benefits of NSPs [11,42]. Ongoing police
crackdowns, arrests and confinement substantially dis-
courage IDUs from contacting peer health educators and
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lice are supportive of NSPs, coverage of the programs
quickly increased and risk behaviors decreased [43].
Without effective cooperation between legislation, law
enforcement and health policy sectors, NSPs are unlikely
to reach a sufficient proportion of IDUs to make a sig-
nificant impact on China’s HIV epidemic.
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